3 hours AnaptysBio, Inc. (NASDAQ:ANAB) Receives Consensus Recommendation of “Moderate Buy” from Analysts MarketBeat
Shares of AnaptysBio, Inc. (NASDAQ:ANAB – Get Free Report) have received a consensus rating of “Moderate Buy” from the eleven research firms that are currently covering the company, MarketBeat Ratings reports. Two research analysts have rated the stoc…